ask="3.25"
ask_size="1500"
average_daily_volume="156182"
bid="2.01"
bid_size="100"
book_value="0.74"
change="-0.10"
change_from_200_day_moving_average="0.18"
change_from_50_day_moving_average="-0.04"
change_from_52_week_high="-1.02"
change_From_52_week_low="1.34"
change_in_percent="-3.45%"
close="2.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.96"
ex_dividend_date="N/A"
float_shares="21613000"
high="2.90"
high_52_weeks="3.82"
last_trade_date="1/26/2017"
last_trade_price="2.80"
last_trade_size="300"
last_trade_time="4:00pm"
low="2.80"
low_52_weeks="1.46"
market_capitalization="95.61M"
moving_average_200_day="2.62"
moving_average_50_day="2.84"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="5.83"
open="2.82"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+6.93%"
percent_change_from_50_day_moving_average="-1.41%"
percent_change_from_52_week_high="-26.70%"
percent_change_from_52_week_low="+91.78%"
previous_close="2.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.90"
price_per_sales="22.25"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="3.18"
stock_exchange="NGM"
symbol="FATE"
volume="55483"
weeks_range_52="1.46 - 3.82"
